These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 16225353)

  • 21. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
    Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
    Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methadone-Induced Neurotoxicity in Advanced Cancer: A Case Report.
    Hoff AM; Hartwig KN; Rosielle DA
    J Palliat Med; 2017 Sep; 20(9):1042-1044. PubMed ID: 28488910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceutics: choice of a strong analgesic for cancer patients.
    Reich SD
    Cancer Nurs; 1982 Feb; 5(1):67-9. PubMed ID: 6121621
    [No Abstract]   [Full Text] [Related]  

  • 24. Very-high-dose methadone with minimal toxicity and inadequate pain control in a hospice patient with cancer.
    Latuga NM; Wahler RG
    J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):143-9. PubMed ID: 23646910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Use of rectal medications in palliative care.
    Darke AC; Babul N
    J Pain Symptom Manage; 1997 Jun; 13(6):314-5. PubMed ID: 9204647
    [No Abstract]   [Full Text] [Related]  

  • 26. Methadone:effective analgesia, confusion, and risk.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2005; 19(2):3-5. PubMed ID: 16061455
    [No Abstract]   [Full Text] [Related]  

  • 27. Methadone: starting dosing information No. 86.
    von Gunten CF
    J Palliat Med; 2004 Apr; 7(2):304-5. PubMed ID: 15130210
    [No Abstract]   [Full Text] [Related]  

  • 28. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
    Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
    J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A German model for methadone conversion.
    Nauck F; Ostgathe C; Dickerson ED
    Am J Hosp Palliat Care; 2001; 18(3):200-2. PubMed ID: 11406897
    [No Abstract]   [Full Text] [Related]  

  • 30. Methadone in end-of-life pain management.
    Chau DL; Mason MN
    J Opioid Manag; 2005; 1(5):244-8. PubMed ID: 17319557
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of Very-Low-Dose Methadone and Haloperidol for Pain Control in Palliative Care Patients: Are the Sigma-1 Receptors Involved?
    Cobos EJ; Baeyens JM
    J Palliat Med; 2015 Aug; 18(8):660. PubMed ID: 26087240
    [No Abstract]   [Full Text] [Related]  

  • 32. Methadone as an additional opioid for a cancer patient with severe neuropathic and bone pain not responsive to other opioids and adjuvant analgesics.
    Leppert W; Kowalski G
    J Palliat Care; 2013; 29(2):119-21. PubMed ID: 23923476
    [No Abstract]   [Full Text] [Related]  

  • 33. Patient-controlled analgesia with intravenous L-methadone in a child with cancer pain refractory to high-dose morphine.
    Sabatowski R; Kasper SM; Radbruch L
    J Pain Symptom Manage; 2002 Jan; 23(1):3-5. PubMed ID: 11779660
    [No Abstract]   [Full Text] [Related]  

  • 34. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report.
    Salpeter SR; Buckley JS; Buckley NS; Bruera E
    J Palliat Med; 2015 Feb; 18(2):114-9. PubMed ID: 25494475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine to methadone conversion: an interpretation of published data.
    Pollock AB; Tegeler ML; Morgan V; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Mar; 28(2):135-40. PubMed ID: 20555039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary Validation for the "BJR method"-A Possible New Mathematical Approach to Methadone Conversion.
    Trofimovitch D; Hutchinson L; Baumrucker SJ
    J Pain Palliat Care Pharmacother; 2019; 33(1-2):42-48. PubMed ID: 31260376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracerebroventricular morphine for refractory cancer pain: transitioning to the home setting.
    Adolph MD; Stretanski MF; McGregor JM; Rawn BL; Ross PM; Benedetti C
    Am J Hosp Palliat Care; 2010 Aug; 27(5):326-32. PubMed ID: 20103784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and side effects of continuous infusion intravenous morphine (CIVM) for pain and symptoms due to advanced cancer.
    Glare P; Walsh D; Groh E; Nelson KA
    Am J Hosp Palliat Care; 2002; 19(5):343-50. PubMed ID: 12269781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.